Apoptotic Nuclei Within the Uterine Decidua of First Trimester Pregnancy Arise from CD45 Positive Leukocytes
- 1 August 1999
- journal article
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 42 (2) , 88-94
- https://doi.org/10.1111/j.1600-0897.1999.tb00471.x
Abstract
The Fas/Fas-ligand (FasL) system is discussed to be one of the main components responsible for the formation and maintenance of an immune privilege. As we were able to detect FasL on fetal trophoblast cells infiltrating the maternal uterine tissue and Fas on decidual leukocytes (Hammer et al., Am J Reprod Immunol, 1999; 41: 41-51), we investigated whether apoptosis occurs in the maternal decidua during the first trimester of pregnancy. A TUNEL-assay was performed in combination with immunofluorescence to detect and characterize cells undergoing apoptosis. Apoptotic nuclei mainly arising from CD45+ leukocytes could be detected in the trophoblast-invaded decidua basalis as well as in the non-invaded decidua parietalis. However, while in the decidua parietalis the apoptotic leukocytes are scattered within the whole functional stroma, in the decidua basalis they are concentrated in the area around the so-called "necrotic foci" and especially in the primary feto-maternal contact zone. where trophoblast cells from the cell columns begin to invade the maternal tissue. Because of the irregular distribution of apoptotic CD45+ leukocytes in the decidua basalis we think that some of the maternal leukocytes are activated and killed by fetal trophoblast cells which express FasL.This publication has 40 references indexed in Scilit:
- Fas and FasL in the homeostatic regulation of immune responsesPublished by Elsevier ,2001
- Apoptosis, bcl-2 Expression, and Proliferative Activity in Human Endometrial Stroma and Endometrial Granulated Lymphocytes1Biology of Reproduction, 1998
- Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues.Molecular Pathology, 1997
- Expression of HLA class I molecules in human first trimester and term placenta trophoblastCell and tissue research, 1996
- Prevention of Islet Allograft Rejection with Engineered Myoblasts Expressing FasL in MiceScience, 1996
- Fas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeScience, 1995
- A role for CD95 ligand in preventing graft rejectionNature, 1995
- Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection.The Journal of Experimental Medicine, 1992
- Immunocytochemical characterization of the unusual large granular lymphocytes in human endometrium throughout the menstrual cycleHuman Immunology, 1989
- An Immunohistochemical Study of Lymphoid Tissue in Human EndometriumInternational Journal of Gynecological Pathology, 1988